The additional activation step matters
The FDA label identifies calcifediol as a prohormone converted to calcitriol, mainly in the kidney. Calcitriol then binds the vitamin D receptor and increases intestinal calcium and phosphorus absorption while reducing parathyroid hormone synthesis. [1]
Calling both products vitamin D does not erase this chemical difference. Calcifediol, cholecalciferol and calcitriol are not simply alternative names for the same preparation. [1]
The extended-release label describes a specific population
The cited January 2024 US label indicates extended-release calcifediol for secondary hyperparathyroidism in adults with stage 3 or 4 chronic kidney disease and serum total 25-hydroxyvitamin D below 30 ng/mL. It does not indicate this product for stage 5 disease or dialysis. [1]
The label requires monitoring calcium, phosphorus, vitamin D and parathyroid hormone. Excess exposure can cause high blood calcium, and overly suppressed parathyroid hormone is another concern. These product-specific instructions are not a general self-treatment schedule. [1]
Compare names before comparing numbers
Imagine two prescriptions list calcifediol and calcitriol. Even if their quantities use the same unit, the matching unit does not establish dose equivalence or permission to substitute one for the other.
| Detail | Interpretation |
|---|---|
| Calcifediol | 25-hydroxy precursor |
| Calcitriol | Active form |
| Extended-release product | Specific labeled indication |

Sources for this article
- RAYALDEE
Source consulted: 2026-09-19. This is a reference resource, not a claim that we conducted the studies or tested a product.